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Retroviral genomes are dimeric, comprised of two sense-strand RNAs linked at their 5 ends by noncovalent
base pairing and tertiary interactions. Viral maturation involves large-scale morphological changes in viral
proteins and in genomic RNA dimer structures to yield infectious virions. Structural studies have largely
focused on simplified in vitro models of genomic RNA dimers even though the relationship between these
models and authentic viral RNA is unknown. We evaluate the secondary structure of the minimal dimerization
domain in genomes isolated from Moloney murine leukemia virions using a quantitative and single nucleotide
resolution RNA structure analysis technology (selective 2-hydroxyl acylation analyzed by primer extension, or
SHAPE). Results are consistent with an architecture in which the RNA dimer is stabilized by four primary
interactions involving two sets of intermolecular base pairs and two loop-loop interactions. The dimerization
domain can independently direct its own folding since heating and refolding reproduce the same structure as
visualized in genomic RNA isolated from virions. Authentic ex virio RNA has a SHAPE reactivity profile similar
to that of a simplified transcript dimer generated in vitro, with the important exception of a region that appears
to form a compact stem-loop only in the virion-isolated RNA. Finally, we analyze the conformational changes
that accompany folding of monomers into dimers in vitro. These experiments support well-defined structural
models for an authentic dimerization domain and also emphasize that many features of mature genomic RNA
dimers can be reproduced in vitro using properly designed, simplified RNAs.
Retroviruses, including both simple model viruses and com-
plex viruses like human immunodeficiency virus (HIV), con-
tain genomes in the form of two coding RNA strands, nonco-
valently linked at their 5 ends (11, 19, 20, 26, 38, 45). This 5
linkage is termed the genomic RNA dimer. Packaging of RNA
genomes into new virions is highly specific, even in the pres-
ence of a large background of cellular RNA (1, 7, 26). This
packaging function is carried out by the Gag protein (14, 30,
43), which recognizes RNA sequences that overlap with the
RNA dimerization domain (16, 26, 42, 44). The specific Gag-
dimer interaction represents an elegant and direct mechanism
by which exactly two RNA genomes are packaged into each
nascent virion.
The genomic RNA dimer is initially assembled into an im-
mature and noninfectious viral particle (9, 18–20). After the
immature particle buds from the host cell, it undergoes exten-
sive morphological changes to form the mature and infectious
virion (21, 51). Maturation is initiated through cleavage of the
Gag polyprotein by the viral protease to yield smaller Gag-
derived proteins and also involves changes in the structure of
the RNA dimer region. The RNA dimer structure appears to
be more compact and, for many retroviruses, more thermo-
stable in mature than in immature virions (18–20, 26).
The closely related Moloney murine leukemia and sarcoma
viruses (MuLV and MuSV, respectively) have served as im-
portant model systems for studying factors that impact retro-
viral infectivity. Recent work indicates that a compact region of
170 nucleotides (nt) in MuLV and MuSV is sufficient for
dimerization in vitro (6). This dimerization region overlaps
with sequences that were previously shown to be sufficient to
allow heterologous RNAs to be packaged, albeit at reduced
levels, as dimers into new virions (26). This region also forms
high-affinity interactions with the viral Gag protein (16). Struc-
tural analysis of this minimal dimerization active sequence (the
MiDAS RNA), performed with highly purified RNA under
simplified solution conditions in vitro, supports a consensus
model for the dimerization domain that involves three major
structural components (Fig. 1) (4, 5, 22). Two conserved self-
complementary sequences, PAL1 and PAL2 (5, 22, 24, 32, 39)
(also called SL-B and SL-B, respectively), form extended in-
termolecular duplexes. A conserved double stem-loop domain,
SL1-SL2 (29) (also called SLC-SLD), forms stable loop-loop
and tertiary interactions with the same domain in the second
RNA strand (4, 5, 22, 28).
To date, there are important gaps in our basic understanding
of retroviral dimerization. First, with three exceptions (2, 40,
49), structural analysis of dimerization has focused on detailed
characterization of simplified RNA transcripts in vitro. Dimer-
ization in vitro is usually achieved by incubating an RNA at
elevated temperatures, and it is unclear whether this appropri-
ately mimics dimerization in vivo, which is facilitated by the
chaperoning and strand-annealing activities of the viral nucleo-
capsid protein (31, 43). Thus, the correlation between RNA
structures observed in vitro versus those that exist in virions is
unknown.
Second, while there is an emerging consensus that a compact
region in the MuLV and MuSV RNA genomes mediates
dimerization both in vitro and in vivo, in vitro structural anal-
* Corresponding author. Mailing address: Department of Chemis-
try, University of North Carolina, A008 Kenan Labs, CB-3290, Chapel
Hill, NC 27599-3290. Phone: (919) 962-7486. Fax: (919) 962-2388.
E-mail: weeks@unc.edu.
 Published ahead of print on 4 November 2009.
898
yses have led to different, conflicting models for the dimeriza-
tion domain. Key areas of disagreement include the bound-
aries of the PAL1 and PAL2 duplexes, the structures of the
RNA elements between these helices, and the nature of the
conformational changes that accompany formation of the au-
thentic retroviral dimer (compare references 4–6, 13, 14, and
47). In addition, some studies have been performed with RNAs
that either contain many mutations relative to the native se-
quence or span only a portion of the 170-nt dimerization
element. Differences in these models and in the choice of
simplified RNA are important because they influence whether
the dimerization domain forms higher-order tertiary interac-
tions (4, 5), make different predictions regarding how Gag and
nucleocapsid bind (5, 13), and affect the choice of RNAs used
in high-resolution structural studies (13, 14).
To address these issues, we use RNA SHAPE (selective
2-hydroxyl acylation analyzed by primer extension) chemistry
(35, 50) to map the structure of authentic genomic RNA that
has been gently extracted from infectious virions (termed the
ex virio RNA). SHAPE uses an electrophilic reagent, 1M7
(1-methyl-7-nitroisatoic anhydride) (37), that reacts selectively
at the 2-hydroxyl position of flexible nucleotides to form 2-
O-ester adducts. The reaction occurs preferentially at flexible
RNA sites because these nucleotides are better able to adopt
local conformations that enhance the reactivity of the 2-hy-
droxyl group (23, 35). SHAPE reactivities thus correlate in-
versely with the probability that a nucleotide forms base pair-
ing or tertiary interactions. SHAPE information can be used to
create highly accurate models for an RNA secondary structure
(12, 49).
Although not every base pairing interaction is predicted
perfectly, benchmarking experiments indicate that SHAPE-
constrained RNA secondary structure determination yields
models for large RNAs that include 95% or greater of the
accepted base pairs (12). SHAPE reactivity patterns typically
yield quantitative information for nearly every nucleotide in an
RNA. SHAPE profiles are thus helpful in ruling out incorrect
or incomplete models. To provide a basis for interpreting the
structure of authentic MuLV genomic RNA, we also compared
the structure of the virion-derived dimer RNA with in vitro
transcripts of both dimer and monomer states.
Secondary structure models derived from SHAPE measure-
ments for the ex virio (genomic RNA isolated from mature
MuLV particles) and in vitro (short, transcribed RNA, incu-
bated at 60°C) dimers are highly similar but not identical.
These data provide critical evidence that in vitro dimerization
recapitulates most elements associated with the structure of
the mature retroviral dimer. We also assess the structure of the
dimerization domain in the context of the 8,300-nt ex virio
RNA following denaturation and subsequent refolding by in-
cubation at 60°C. The structure of this refolded genomic RNA
is nearly identical to the structure of authentic genomic RNA
as initially isolated from virions and is similar to the dimer
generated from short transcripts in vitro. Collectively, these
results provide a well-justified model for the structure of au-
thentic MuLV genomic RNA and emphasize that the dimer
created artificially in vitro closely mimics, but does not yet
perfectly recapitulate, the structure of the mature dimer ob-
tained from virions.
MATERIALS AND METHODS
Virus preparation. Virions were obtained from 10 liters of clarified cell culture
supernatant from a constitutively producing cell line infected with MuLV (cell
line SL658 DN, the NB-tropic, IC isolate of Moloney MuLV propagated in
3T3FL cells) (17). Virus was recovered from culture fluids by single or double
banding in sucrose gradients (10). Virus pellets were resuspended in TNE (0.01
M Tris-HCl [pH 7.2], 0.1 M NaCl, and 1 mM EDTA) buffer at final concentra-
tions of 1,000 or 5,000, relative to the starting culture volume, and aliquots
were stored at 70°C.
Ex virio RNA dimer extraction and quantification. For isolation of whole
MuLV genomic RNA, concentrated virion preparations (equivalent to 2 
1013 genomes) were collected by ultracentrifugation (Beckman SW-41 rotor;
235,000  g at 4°C for 1 h). Pellets were resuspended in 1 ml of lysis buffer (50
mM Tris [pH 7.4], 10 mM EDTA, 1% [wt/vol] SDS, 100 mM NaCl, 100 g/ml
proteinase K, 120 g/ml glycogen), incubated at 25°C for 45 min, and extracted
three times with an equal volume of phenol-chloroform-isoamyl alcohol (25:
24:1) and once with an equal volume of chloroform. Samples were precipitated
in 70% ethanol with 0.3 M sodium acetate and stored at 20°C. RNA quantities
were determined by real-time reverse transcriptase PCR (46), using an MuLV
gag transcript from XhoI-linearized pJB2733 (GenBank accession no. J02255; nt
1 to 1560 contained in an XhoI-SpeI fragment, cloned into the homologous sites
of pBluescript KS [Stratagene]) and quantifying the resulting gag cDNA target
(nt 681 to 757; forward primer, 5-CGG ATC GCT CAC AAC CAG T-3;
reverse primer, 5-AAG GTT GGC CAT TCT GCA GA-3; fluorescent probe,
5-FAM-TAG ATG TCA AGA AGA GAC GTT GGG TTA CCT-TAMRA-3,
where FAM is 6-carboxyfluorescein and TAMRA is 6-carboxytetramethylrho-
damine).
Retroviral RNA transcripts. The in vitro MuLV RNA construct contained 331
nt and spanned sequences corresponding to PAL1 through SL2, plus flanking 5
and 3 viral sequences of 46 and 115 nt, respectively (Fig. 1). The DNA template
for in vitro transcription was generated by PCR from a full-length wild-type
MuLV proviral plasmid (25), pRR88 (GenBank accession no. J02255). Tran-
scription reactions (500 l at 37°C for 6 h) contained 80 mM HEPES (pH 7.5),
40 mM dithiothreitol (DTT), 0.01% (vol/vol) Triton X-100, 2 mM spermidine, 10
mM MgCl2, 2 mM each nucleoside triphosphate (dNTP), 25 g of DNA
template, 250 U of SUPERase-In (Ambion), and 0.07 mg/ml T7 RNA polymer-
ase. The RNA was purified by denaturing gel electrophoresis (6% [wt/vol] poly-
acrylamide, 7 M urea), excised from the gel, eluted overnight into 1/2 TBE (45
mM Tris-borate [pH 8], 1 mM EDTA) buffer at 4°C, concentrated by ethanol
precipitation, and stored in 1 TE (10 mM Tris [pH 8], 1 mM EDTA) buffer at
20°C.
SHAPE analysis. Authentic ex virio RNA, isolated from MuLV virions, was
simply allowed to preequilibrate in dimerization buffer (50 mM HEPES [pH 7.5],
200 mM potassium acetate [pH 7.5], 5 mM MgCl2) for 15 min. For the renatured
MuLV genomic RNA and for the in vitro generated RNAs, renaturation was
accomplished by heating at 90°C for 3 min in water (2 pmol in 10 l), snap-
cooling on ice for 2 min, and treating with 3 dimerization buffer (6 l; 150 mM
HEPES [pH 7.5], 600 mM potassium acetate [pH 7.5], 15 mM MgCl2). Mono-
mers were allowed to equilibrate for 2 min at 37°C prior to modification (see
below); dimers were created by heating (30 min at 60°C). Use of our RNA
FIG. 1. Organization of structural elements in the MuLV dimer-
ization domain. Major dimerization elements are indicated: PAL1 and
PAL2, palindromic sequences; SL1-SL2, stem-loop domain. The min-
imal dimerization active sequence (MiDAS) is 170 nt; the in vitro
transcript used in this work spans 331 nt. The binding site for the
fluorescent DNA primers used for primer extension is represented by
a backward-facing arrow.
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construct and this refolding procedure yields very homogeneous dimer and
monomer states as visualized by nondenaturing gel electrophoresis (data not
shown). 2-Hydroxyl modification for SHAPE was performed by treating MuLV
RNA or transcript RNA (in 9 l) with 1-methyl-7-nitroisatoic anhydride (1M7)
(1 l; at 20 mM) in anhydrous dimethyl sulfoxide (DMSO) (37) for 2 min (8
half-lives) at 37°C. Control reactions were obtained by the addition of DMSO,
omitting 1M7. The reaction mixtures were recovered by ethanol precipitation
and resuspended in 6 l of 1/2 TE buffer.
Primer extension. DNA primers (5-GGU GCA CCA AAG AGU CCA AAA
GC-3, labeled with fluorophore Cy5, Cy5.5, or IR800) anneal with a comple-
mentary native viral sequence 47 nucleotides 3 of the MuLV dimerization
domain (nt 422 to 445). Primers (0.5 l; 2 pmol) were annealed to the modified
RNA (6 l; 1 pmol in 1/2 TE buffer) by heating at 65°C and 45°C for 5 min.
Reverse transcription buffer (3 l; 167 mM Tris [pH 8.3], 250 mM KCl, 10 mM
MgCl2, 1.67 mM each dNTP, 16.7 mM DTT) was added, and primer extension
was performed with Superscript III reverse transcriptase (0.5 l; 100 U) at 45°C
(1 min), followed by incubation at 52°C and 65°C, for 5 min each. Reactions were
quenched by cooling at 4°C and the addition of 3 M sodium acetate, pH 5.2 (1
l). A dideoxy guanosine sequencing marker was generated by adding 0.25 l
ddCTP (10 mM) to the primer extension reaction mixture, using unmodified
RNA. The three reaction mixtures (with and without 1M7 and dideoxy sequenc-
ing) were combined, precipitated with ethanol, and resuspended in deionized
formamide (40 l). cDNA fragments were resolved by capillary electrophoresis
using a Beckman CEQ 2000XL capillary electrophoresis instrument.
Data processing and structure prediction. Raw sequencer traces were cor-
rected for dye variation and signal decay, and peak intensities were integrated
using ShapeFinder (48). Reactivities were normalized by dividing the absolute
peak intensities by the average of the 8% (14 nt) most reactive peaks after
exclusion of the first 2% (3 nt). SHAPE reactivity information was used to
impose a pseudo-free energy change constraint, in conjunction with nearest-
neighbor thermodynamic parameters, using the algorithm in RNAstructure (12, 34).
RESULTS
SHAPE analysis of MuLV genomic RNA. The overarching
goal of this work was to develop a model for the global archi-
tecture and secondary structure of the dimerization domain for
authentic MuLV retroviral RNA genomes isolated from viri-
ons. We therefore used single nucleotide resolution SHAPE
chemistry to analyze the structure of the dimerization domain
(Fig. 1) from genomic MuLV RNA purified from virions under
nondenaturing conditions that preserve the dimeric and ther-
mostable state of the RNA (20, 26). We term this RNA the ex
virio dimer.
The output from a SHAPE experiment includes three com-
ponents (Fig. 2): a trace of the reaction with reagent (plus-
reagent trace)(Fig. 2, black trace), a background trace that
omits the reagent (Fig. 2, gray trace), and a deoxynucleotide
sequencing ladder which is used to assign the positions of sites
reactive toward 1M7. Nucleotides tagged with 2-O-adducts
are detected as stops to reverse transcriptase-mediated primer
extension. Extension reactions are performed using fluores-
cently labeled DNA primers and resolved by capillary electro-
phoresis (37, 48, 49) (Fig. 2). We computed the absolute re-
activity at each nucleotide within the MuLV ex virio RNA by
integrating individual peak areas and subtracting the back-
ground from the plus-reagent areas. Conformationally flexible
nucleotides appear as tall peaks, whereas nucleotides that par-
ticipate in strong base pairing or tertiary interactions have
reactivities near the background (Fig. 3A, compare red and
black columns).
Structure of the dimerization domain for MuLV. We devel-
oped a secondary structure model for the dimerization region
of ex virio MuLV genomic RNA using SHAPE reactivity in-
formation to impose a pseudo-free energy change constraint in
a thermodynamics-based RNA structure prediction algorithm
(12, 34). We show the resulting secondary structure model anno-
tated by the nucleotide resolution SHAPE reactivity (Fig. 3B).
SHAPE analysis of the MuLV ex virio RNA supports a
model in which the major structural domains are similar to a
prior consensus model based on analysis of the closely related
MuSV sequence (5). Sequences comprising the PAL1 and
FIG. 2. SHAPE reactivities in the 190- to 375-nt region for the authentic 8,300-nt MuLV genomic RNA extracted from virions (A), the in
vitro dimer (B), and the monomer state (C), resolved by capillary electrophoresis. 1M7 traces with and without reagent are shown in black and gray,
respectively.
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PAL2 intermolecular duplexes are unreactive. Similarly, base-
paired positions in the SL1 and SL2 stem-loops are unreactive
except at bulged nucleotides, as shown in our model. Modeling
is also consistent with a large, previously unidentified, struc-
tured stem-loop region between PAL1 and PAL2, which we
term SL0. Finally, the dimer structure contains three highly
flexible elements. These lie immediately 3 to PAL1 (positions
220 to 235) and PAL2 (positions 299 to 309) and in the large
terminal loop in SL0 (positions 253 to 267) (Fig. 3B).






































































































































































































































































































































































































































 MuLV genomic RNA
FIG. 3. SHAPE reactivities and secondary structure model for the ex virio MuLV genomic RNA dimer. (A) Histogram of SHAPE reactivities
for authentic ex virio MuLV genomic RNA isolated from virions. (B) Secondary structure model for the ex virio dimer. Nucleotides are colored
according to their reactivity as shown in panel A. For clarity, only one of the two dimer strands is annotated in color; a small number of nucleotides
in the colored strand (in gray) were not analyzed due to high background. Nucleotide differences between MuLV and MuSV are circled. The
nucleocapsid binding site characterized by NMR (13) plus a similar site accessible in the SHAPE-constrained secondary structure are highlighted
in solid and dashed boxes, respectively. (C) Comparison of the SHAPE profiles for the ex virio RNA with that of the same RNA that has been
heated (to 90°C) and renatured in vitro. The y-axis scale is the same as that used in panel A. (D) Structure model for the region of the in vitro dimer
that corresponds to the SL0 motif in the ex virio RNA.
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been using heating and quick-cooling to reduce the RNA to a
monomeric state and then initiating dimerization by incubation
at an elevated temperature. We subjected the authentic ex virio
MuLV RNA to a heat denaturation and renaturation protocol
(see Materials and Methods) and then analyzed the structure
of the RNA by SHAPE. The resulting SHAPE profiles are
shown using step histograms (Fig. 3C). The pattern of reactiv-
ity is almost identical to that for the gently purified native,
heat-denatured and -renatured RNA. This experiment indi-
cates that accurate RNA folding and dimerization can be in-
duced by a simple heating and refolding procedure, at least in
this region of the MuLV genome.
An in vitro RNA dimer folds similarly to the authentic dimer
isolated from virions. We next sought to assess how closely the
authentic ex virio genomic RNA resembles a dimer formed in
vitro using a simplified transcript RNA that spans the dimer-
ization domain. We compared SHAPE reactivity profiles for
the dimerization domain of genomic RNA extracted from viri-
ons with that of a 331-nt transcript (Fig. 4A, compare black
and gray histograms). Differences between these two RNAs
are readily visualized by subtracting individual nucleotide re-
activities for the in vitro dimer from values of the ex virio dimer
(Fig. 4B).
SHAPE profiles for the ex virio and in vitro dimers are nearly
superimposable in all regions spanning the key elements—
PAL1, PAL2, and the SL1-SL2 domain—that function to sta-
bilize the dimer state (4, 22) (Fig. 4). These results imply that
the structure of the in vitro dimer closely resembles that of the
ex virio dimer.
Despite this overall pattern of nearly identical reactivities,
important differences are observed between the ex virio and in
vitro dimers (Fig. 4B, difference plot). Nucleotides 243 to 252
are unreactive in the ex virio dimer, whereas these nucleotides
are reactive in the in vitro dimer. Other nucleotides (253, 254,
and 259 to 261) are also less reactive in the dimer RNA ex-
tracted from virions. Immediately 5 to this region (positions
220 to 235) the reverse occurs such that these nucleotides are
more reactive in the ex virio RNA than in the in vitro dimer
(Fig. 4B).
These data support the interpretation that the structure be-
tween PAL1 and PAL2 is different in the two RNAs and that
this region forms the SL0 stem-loop only in the genomic RNA
(structural differences between the ex virio and in vitro dimers
are illustrated in Fig. 3B and D). The SHAPE reactivity pat-
tern for the ex virio dimer is robust and persists even if the ex
virio RNA is denatured by heat treatment and allowed to
redimerize in vitro (Fig. 3C). These data suggest that this re-
gion may form long-range interactions in the 8,300-nt long
genomic RNA or that folding and dimerization kinetics are
altered in the intact RNA relative to short in vitro transcripts.
Structure of the in vitro MuLV monomer. We next used
SHAPE reactivity information (Fig. 2C) to establish a second-
ary structure model for the MuLV monomer state. In contrast
to the general similarity between the ex virio genomic RNA and
the in vitro dimer, there are extensive differences between the
in vitro monomer and both the ex virio and in vitro dimers which
occur throughout the RNA (Fig. 5). In PAL1, nucleotides 214
to 221 are highly reactive in the monomer while positions 205
to 213 and 222 to 227 are unreactive, consistent with formation
of a stem-loop (Fig. 6A). Nucleotides 228 to 229 are flexible,
supporting the existence of a linker that connects the PAL1
stem-loop to the rest of the monomer. Nucleotides in the
SL1-SL2 domain (316 to 370) have a low reactivity overall,
suggesting extensive base pairing and tertiary interactions in
this region. SL1 is punctuated with a few flexible nucleotides
(319 and 337 to 341), consistent with formation of two distinct
FIG. 4. Comparison of SHAPE reactivities for MuLV ex virio dimers with dimers created in vitro using short (331 nt) RNA transcripts.
(A) Reactivity histograms for the ex virio (black) and in vitro (gray) dimers. (B) Difference plot calculated by subtracting the in vitro dimer
intensities from those of the ex virio dimer. Positive and negative amplitudes indicate nucleotides that are more flexible in the ex virio and in vitro
dimers, respectively.
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bulges. Reactive nucleotides between positions 350 and 354
indicate that a flexible linker connects SL1 and SL2. Between
the PAL1 stem-loop and the SL1-SL2 domain, nucleotides 231
to 241 and 305 to 315 are constrained while the majority of the
positions in the intervening region (nt 242 to 304) are reactive.
This pattern of reactivity suggests that nucleotides 242 to 304
form a flexible domain which is linked to the rest of the RNA
via a stable anchoring helix (Fig. 6A). A similar architecture
was identified and proposed previously for MuSV (6).
Within the flexible domain, no single structure completely
explains the overall pattern of reactivity. For example, in the
most stable predicted structure for MuLV, PAL2 forms a stem-
loop (supported by low reactivity at nt 279 to 287 and 295 to
299 and high reactivity for nt 288 to 294) (Fig. 5A and 6A).
However, this structure contains local inconsistencies. For ex-
ample, nucleotides 243 and 244 are reactive but are predicted
to be paired in this contributing structure (Fig. 6A). We favor
a model in which the flexible domain does not form a single
structure but, instead, exists in equilibrium between multiple
secondary structures (compare Fig. 6A and B). Two intercon-
verting structures, which differ by only 2 kcal/mol, appear to
be sufficient to account for the global pattern of SHAPE re-
activity.
DISCUSSION
A structure for authentic MuLV genomic RNA in the dimer
state. The retroviral genomic RNA dimer structure was first
visualized in electron micrographs of genomic RNA from sev-
eral retroviruses. Subsequent work has made it clear that most
retroviruses form a stable dimeric structure near their 5 ends
(8, 27, 33, 38). The dimer element appears to play a critical role
in retroviral replication by creating the specific three-dimen-
sional structure that is ultimately recognized by Gag during
viral RNA packaging (9, 41, 45). The dimer state likely also
functions to ensure that two copies of each genome are pack-
aged into each virion and to facilitate recombination between
genomes (3, 36).
Several convergent results, including this work, are now avail-
able to guide development of a model for the overall architec-
ture and secondary structure of the dimerization domain in
MuLV. First, the minimal RNA elements that are required to
bind Gag (16) and are sufficient to direct a modest level of
packaging in vivo (26) have become better defined. These el-
ements overlap with the elements required to form a dimeric
state in vitro (5, 6, 24, 32, 39, 47). As defined by all three
experimental approaches, the minimal dimerization element
appears to span 170 nt.
Second, using authentic genomic RNA purified from MuLV
virions, we have obtained a comprehensive SHAPE reactivity
profile for the entire dimerization domain (Fig. 3A). The
SHAPE information places very strong constraints on possible
secondary structure models and rules out many alternative
models.
Finally, heating and then refolding the genomic RNA yields
the same SHAPE reactivity profile as observed for the RNA as
isolated from virions. Thus, although RNA folding may be
facilitated by other factors and chaperone activities in vivo, the
MuLV genomic RNA itself appears to contain all the infor-
mation required for folding of the dimerization domain.
All elements previously proposed to be important for dimer
FIG. 5. SHAPE reactivities for the RNA transcript in vitro dimer and monomer states. (A) Reactivity histograms for the in vitro dimer (gray)
and monomer (black). Lines are interrupted for nucleotides that were not analyzed due to high background reactivity. (B) Difference plot
calculated by subtracting the monomer intensities from those of the dimer. Positive and negative values indicate nucleotides that are more flexible
in the dimer and the monomer, respectively.
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formation are well defined in the structure of the MuLV
dimerization domain (Fig. 3B). PAL1 and PAL2 form inter-
molecular duplexes of 10 and 16 bp, respectively. SL1 and SL2
form well-defined stem-loop structures. The GACG sequences
at the termini of the stem-loops are unreactive, which we
interpret in terms of formation of stable long-range loop-loop
interactions (4, 22, 28) (Fig. 6C, indicated in orange).
The structure of authentic mature MuLV genomic RNA
FIG. 6. Secondary structure of the MuLV MiDAS RNA monomer and its conversion to the dimer state. (A) Structure of the entire MiDAS
monomer. Nucleotides are colored using the scale shown in Fig. 3A. (B) Alternate structure proposed to interconvert with the domain of
nucleotides 231 to 315. Nucleotides that differ in MuLV compared to MuSV are circled. (C) Cartoon of the dimer state emphasizing the regions
undergoing the largest conformational changes upon dimerization. The full nucleotide sequence is given in Fig. 3B.
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dimers, comprised of two strands of 8,300 nt, is very similar,
but not identical, to the structure generated using short tran-
scripts and a heating and refolding step in vitro (Fig. 4). Spe-
cific differences between the in vitro generated versus ex virio
dimer are localized to sequences between PAL1 and PAL2
(Fig. 3B and D). We have interpreted these differences to
indicate that the authentic ex virio dimer forms a stem-loop
element that is not present in the in vitro dimer. Genome-
specific differences likely involve additional long-range inter-
actions with flanking RNA sequences not present in current in
vitro models of the dimerization domain.
Conformational changes that characterize dimer formation.
Comparison of the overall reactivity profiles for the MuLV
monomer and dimer states indicates that numerous conforma-
tional changes accompany the in vitro dimerization reaction
(Fig. 5A). These changes are readily visualized in a difference
analysis (Fig. 5B) and show that nucleotides in both PAL1 and
PAL2 sequences change conformation and become unreactive
during this structural transition (Fig. 3B and 6C, green and red
areas). SHAPE reactivities also support the interpretation that
the anchoring duplex melts and that the SL1-SL2 domain un-
dergoes a local conformation change, consistent with elonga-
tion of SL1 by four base pairs during dimerization (Fig. 6C,
indicated in black).
Our laboratory has analyzed two closely related model
systems, MuLV (this work) and MuSV (4, 22). Consistent
with their extensive sequence similarities, the major mono-
mer and dimer structures fold identically in the two vi-
ruses. These elements also undergo similar conformational
changes upon dimerization in vitro (Fig. 6A and C) (5). Al-
though only five positions differ in sequence in the dimeriza-
tion domains of MuLV and MuSV (circled in Fig. 3 and 6),
these differences lead to clear and measurable SHAPE-de-
tected structural differences in the both monomer and dimer
states. These data both show the sensitivity of the SHAPE
approach for detecting small changes in an RNA structure and
also provide additional support for our overall model for the
architecture of the dimerization domains. The sequence dif-
ferences between MuLV and MuSV and the resulting struc-
tural changes occur precisely in the unique unstructured do-
mains in these RNAs and therefore do not compromise the
motifs that form the major stabilizing elements in the dimer.
Implications for future structural studies. The secondary
structure and overall architecture of the dimerization domain
in the MuLV and MuSV gamma retroviruses now appear to be
well defined. The structural models proposed here are broadly
consistent with prior experimental chemical probing data re-
ported for both authentic MuLV genomic RNA (2) and in vitro
models of the dimerization domain (47). However, our inter-
pretation of the SHAPE data differs from prior models. These
differences reflect, in part, the greater coverage of the SHAPE
data relative to conventional RNA mapping reagents and im-
provements in incorporating chemical modification data into
secondary structure prediction methods.
The SHAPE-directed secondary structure models reported
here are also the same as the pattern of base pairing seen in
recent nuclear magnetic resonance (NMR) models of dimer-
ization-related RNAs in the regions where the sequences of
the two RNAs were identical (13, 14). However, the NMR
studies were performed with RNAs that contained only a por-
tion of the dimerization domain, spanning roughly PAL2
through the SL1-SL2 domain, and that also contained extra
sequences 5 of PAL2 and 3 of SL2 and nucleotide changes in
PAL2, SL1, and SL2 that clearly affect the global architecture
of the dimer (14). In the regions in which the NMR studies
used nonnative sequences, the secondary structures defined by
SHAPE and by NMR are different.
The prior NMR work indicated that the MuLV nucleocapsid
protein binds at the single stranded UCUG309 sequence (Fig.
3B, solid box) (13). The revised SHAPE-constrained model
emphasizes that there are two UCUG motifs in the single-
stranded linker between PAL2 and SL1, suggesting that nu-
cleocapsid domains bound in tandem might bind the RNA in
this region (Fig. 3B, dashed box). Both UCUG elements be-
come single stranded in the dimer, consistent with a model
in which selective exposure of these sequences plays a role in
specific recognition of the dimer state by the nucleocapsid
domain of Gag (13, 15). These differences in structure ob-
served for the native MuLV sequence studied here and the
mutated sequence studied by NMR emphasize that small
changes in critical regions change the structure of the MuLV
RNA in ways that are important for understanding viral pro-
tein-RNA interactions.
Dimerization in the MuLV/MuSV system is accompanied by
large-scale and readily detected conformational changes in the
RNA (Fig. 2, 5, and 6). This contrasts with the more difficult
case of HIV type 1, where the monomer and dimer states have
very similar overall SHAPE profiles (49). MuLV may therefore
be the best model for understanding the process of retroviral
RNA genome maturation, first, because the elements sufficient
to recapitulate the biological function of this RNA are becom-
ing well defined and, second, because dimerization yields clear
structural changes as a function of RNA state. Important fu-
ture objectives include indentifying the structural differences
that distinguish mature from immature genomic RNA dimers
and the role that these structures play in maturation of non-
infectious, immature virions to infectious virions.
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